[1]
D. A. Rincón-Valenzuela and C. Gómez-Ardila, “Cost-benefit relationship of keeping dantrolene stocks from the point of view of healthcare institutions”, Colomb. J. Anesthesiol., vol. 48, no. 2, pp. 63–70, Apr. 2020.